Imaging is becoming increasingly important within the framework of molecular and individualized medicine: imaging is implemented in the diagnostic field to capture and depict anatomical relationships and pathological changes with great precision. Additionally, functional characterization of disease characteristics is needed that goes beyond the detection of tissue morphology and extends to the molecular level. Imaging encompasses all methods that are capable of depicting all space- and time-coded morphological, functional, and molecular processes. This can occur at the sub-cellular, cellular, tissue, and organ level. Imaging is increasingly implemented to study the enrichment kinetics, release, and effectiveness of new therapuetic agents. Such theranostic concepts demonstrate a high, clinical potential for development, especially for nanomedical substances and radio immunotherapeutic agents. Imaging is implemented in the interventional sector in order to navigate probes or catheters in the body during minimally invasive therapeutic processes, to locate the source of disease, and to percutaneously treat it in a controlled matter.
The improvement of imaging methods with more detailed, anatomical, functional, and even molecular illustration also makes great demands on the doctor providing treatment. Modern image processing and analysis processes as well as indication-specific contrast agents are needed with shorter and shorter time windows per report, increasing amounts of data, and the need for a pathophysiological daignosis that goes beyond an anatomical description. In the future serum diagnostics, imaging, and systems-biological analysis must be integrated to work together.
Development of ImagingMedST
Imaging allows for therapy-guided diagnosis with the aim of a patient customized therapy.